Method development and validation for the simultaneous determination of rosiglitazone and metformin in pharmaceutical preparations by capillary zone electrophoresis
- 6 September 2005
- journal article
- Published by Elsevier BV in Analytica Chimica Acta
- Vol. 549 (1-2), 88-95
- https://doi.org/10.1016/j.aca.2005.06.014
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Determination of rosiglitazone in coated tablets by MEKC and HPLC methodsJournal of Pharmaceutical and Biomedical Analysis, 2004
- Detection of anti-diabetics in equine plasma and urine by liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2004
- Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetesInternational Journal of Clinical Practice, 2004
- Simple and extractionless high‐performance liquid chromatographic determination of rosiglitazone in human plasma and application to pharmacokinetics in humansBiomedical Chromatography, 2004
- Simplified method for determination of rosiglitazone in human plasmaJournal of Chromatography B, 2004
- Rosiglitazone maleate/metformin hydrochloride: A new formulation therapy for type 2 diabetesDrugs of Today, 2004
- Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standardBiomedical Chromatography, 2003
- Liquid chromatographic method for the determination of rosiglitazone in human plasmaJournal of Chromatography B, 2003
- LC determination of rosiglitazone in bulk and pharmaceutical formulationJournal of Pharmaceutical and Biomedical Analysis, 2002
- Automated high-performance liquid chromatography method for the determination of rosiglitazone in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 2001